The authors identified growth hormone receptor is mainly expressed in mesenchymal cells, and its expression is substantially decreased in idiopathic pulmonary fibrosis lungs.
[Science Advances]
0
Category Archives: Mesenchymal Cell
Mesenchymal Cell NewsMesenchymal Cell News is an online publication and email newsletter that delivers updates on the latest research in the mesenchymal stem cell field.
Mesenchymal Cell News is a weekly email newsletter covering topics such as the isolation, identification, and culturing conditions of mesenchymal stem cells, as well as their cellular characterization, behavior and differentiation capacities. We also include research that focuses on identifying tissue sources of mesenchymal stem cells and their potential therapeutic applications in regenerative medicine and cellular therapies.
Mesenchymal Growth Hormone Receptor Deficiency Leads to Failure of Alveolar Progenitor Cell Function and Severe Pulmonary Fibrosis
Emerging Understanding of Apoptosis in Mediating Mesenchymal Stem Cell Therapy
Investigators summarize the emerging understanding of apoptosis in mediating mesenchymal stem cell transplant, highlighting the potential of apoptotic extracellular vesicles as cell-free therapeutics.
[Cell Death & Disease]
Fu, Y., Sui, B., Xiang, L., Yan, X., Wu, D., Shi, S., & Hu, X. (2021). Emerging understanding of apoptosis in mediating mesenchymal stem cell therapy. Cell Death & Disease, 12(6), 1–12. https://doi.org/10.1038/s41419-021-03883-6 Cite
0
Human Umbilical Cord Mesenchymal Stem Cell Transfusion in Immune Non-Responders with AIDS: A Multicenter Randomized Controlled Trial
The authors examined the safety and efficacy of human umbilical cord mesenchymal stem cell infusion for immune non-responder patients with chronic HIV-1 infection, who represented an unmet medical need even in the era of efficient antiretroviral therapy.
[Signal Transduction and Targeted Therapy]
Wang, L., Zhang, Z., Xu, R., Wang, X., Shu, Z., Chen, X., Wang, S., Liu, J., Li, Y., Wang, L., Zhang, M., Yang, W., Wang, Y., Huang, H., Tu, B., Liang, Z., Li, L., Li, J., Hou, Y., … Wang, F.-S. (2021). Human umbilical cord mesenchymal stem cell transfusion in immune non-responders with AIDS: a multicenter randomized controlled trial. Signal Transduction and Targeted Therapy, 6(1), 1–8. https://doi.org/10.1038/s41392-021-00607-2 Cite
0
Calidi Biotherapeutics Announces Partnership with GenScript ProBio for Distribution of its SuperNova-1 Technology
Calidi Biotherapeutics, Inc. announced its partnership with GenScript ProBio for assistance in the advertisement and distribution of Calidi’s proprietary technology platform: SuperNova-1 (SNV-1). The SNV-1 platform is composed of allogeneic, adipose-derived-MSC loaded with an oncolytic agent such as the vaccinia virus.
[Calidi Biotherapeutics, Inc. (Business Wire, Inc.)]
0
Systematic Review: Advances of Fat Tissue Engineering as Bioactive Scaffold, Bioactive Material, and Source for Adipose-Derived Mesenchymal Stem Cells in Wound and Scar Treatment
Investigators describe the advances in fat tissue engineering applied to regenerative surgery, through the use of adipose-derived-MSCs, stromal vascular fraction contained in lipofilling/fat graft in wound healing and scar treatment.
[Stem Cell Research & Therapy]
0
Endogenous Repair and Regeneration of Injured Articular Cartilage: A Challenging but Promising Therapeutic Strategy
The authors focus on the reasons why articular cartilage (AC) cannot regenerate itself in spite of potential self-repair capacity and summarize the latest developments of the three key components in the field of endogenous AC regeneration.
[Aging and Disease]
0
Tissue Mechanics in Stem Cell Fate, Development, and Cancer
The authors review how dysregulation of tissue-level force increases risk of malignancy, promotes tumor progression, and can induce a stem-like phenotype in tumor cells to drive tumor aggression and treatment resistance.
[Developmental Cell]
0
Novartis Announces Tabrecta® First Published Overall Survival and Updated Overall Response Data in Patients with METex14 Metastatic NSCLC
Novartis AG has announced the first published mature overall survival and updated overall response rate data following treatment with Tabrecta® in adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a mutation that leads to MET exon 14 skipping (METex14).
[Novartis AG]
0
Osteogenic Differentiation of Human Mesenchymal Stromal Cells and Fibroblasts Differs Depending on Tissue Origin and Replicative Senescence
To elucidate cell type-specific differences in the osteogenic differentiation potential and replicative senescence, researchers analyzed the impact of BMP and TGF-β signaling in adipose-derived stromal cells, fibroblasts, and dental pulp stromal cells.
[Scientific Reports]
0
H3K36 Methyltransferase NSD1 Regulates Chondrocyte Differentiation for Skeletal Development and Fracture Repair
Investigators showed that mice with Nsd1 deficiency in Prx1+ mesenchymal progenitors but not in Col2+ chondrocytes showed impaired skeletal growth and fracture healing accompanied by decreased chondrogenic differentiation.
[Bone Research]
0
Cynata Signs Licence Agreement with TekCyte to Advance Clinical Trial in Diabetic Foot Ulcers
Cynata Therapeutics Limited announced the execution of a worldwide exclusive licence agreement with TekCyte Pty Ltd in respect of TekCyte’s wound dressing technology. TekCyte has developed proprietary surface modification technologies to produce polymer-coated dressings for the delivery of MSCs to wounds.
[Cynata Therapeutics Limited (Globe Newswire, Inc.)]
0
